{'output': [['Advanced Medical Isotope Corporation', 'COMP', 'Announce', 'Vivos Inc.', 'PERSON'], ['Vivos Inc.', 'PERSON', 'Operate_In', 'Isotope Applications', 'SECTOR'], ['Vivos Inc.', 'PERSON', 'Introduce', 'RadioGel TM', 'PRODUCT'], ['RadioGel TM', 'PRODUCT', 'Control', 'Yttrium-90', 'ECON_INDICATOR'], ['RadioGel TM', 'PRODUCT', 'Participates_In', 'Brachytherapy', 'PRODUCT'], ['RadioGel TM', 'PRODUCT', 'Impact', 'Tumors', 'CONCEPT'], ['Vivos Inc.', 'PERSON', 'Engage', 'FDA', 'ORG/REG'], ['IsoPet Solutions', 'COMP', 'Focused_On', 'Animal Cancers', 'CONCEPT'], ['RadioGel TM', 'PRODUCT', 'Relate_To', 'Private Animal Clinics', 'COMP'], ['Vivos Inc.', 'PERSON', 'Outsource', 'Manufacturing', 'SECTOR'], ['RadioGel TM', 'PRODUCT', 'Have', 'Short Half-Life', 'ECON_INDICATOR'], ['Vivos Inc.', 'PERSON', 'Plan', 'Licensing Arrangements', 'SECTOR'], ['RadioGel TM', 'PRODUCT', 'Safer', 'Other Brands', 'COMP'], ['Vivos Inc.', 'PERSON', 'Maintain', 'Firm Belief', 'CONCEPT'], ['Vivos Inc.', 'PERSON', 'Grow', 'Shareholder Value', 'CONCEPT']]}